Shanghai Welcomes Merck Investment In Collaboration Center

Merck, a leading science and technology company, opened its M Lab Collaboration Center in Shanghai, the company's largest of nine centers worldwide.

"With the booming pharmaceutical industry in Asia and greater emphasis on novel drug therapies, we see an increase in R&D on leading-edge treatments including cell and gene therapies in China," said Udit Batra, member of the Merck Executive Board and CEO, Life Science. "Our M Lab Collaboration Center offers customizable solutions and services that help bio pharmaceutical and biologics companies improve their processes from drug discovery, development to manufacturing — saving costs and increasing speed to market."

With a total lab size of approximately 10,000m2, Merck's newest M Lab Collaboration Center is located in Pudong, at the heart of the biomedical sciences and research community in Shanghai.

The new M Lab Collaboration Center in Shanghai offers customizable solutions tailored for China's Life Science community to help advance drug development. It includes Pilot Scale and Process Development support labs that offer non-GMP (Good Manufacturing Practice) lab space where pharmaceutical and biopharmaceutical manufacturers can explore ideas, learn innovative techniques and work side-by-side with the company's scientists and engineers to solve critical process development and production challenges. Customers can participate in product demonstrations, hands-on training, formal bioprocessing educational courses and experiments, as well as apply best practices and new approaches to develop, optimize and scale-up processes and simplify global technology transfer.

You May Also Like

Leave a Reply

Your email address will not be published.